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Objectives: We review our surgical experience patients with atriopulmonary
Fontan operations who had obstructive or arrhythmia indications for
conversion to total cavopulmonary artery connections, arrhythmia circuit
cryoablation, and placement of atrial antitachycardia pacemaker. Methods:
Fourteen patients (mean age 14 6 4 years) had conversion to total
cavopulmonary artery connection 8 6 3 years after the original atriopul-
monary Fontan operation primarily for atrial arrhythmias in 11, obstruc-
tive lesions in 2, and bradycardia with cyanosis in 1. Arrhythmia circuit
cryoablation was performed on 11 patients and 10 had atrial antitachycar-
dia pacemakers. Preoperative functional New York Heart Association class
was IV in 9, III in 4, and II in 1. Results: One patient had brain death (7%)
presumably caused by resternotomy complications despite an excellent
hemodynamic result. Another required reoperation for a maldeployed
clamshell device after attempted fenestration closure. Average length of
stay was 10 6 3 days; chest tubes were removed on day 7 6 3. There were
no long-term deaths (mean follow-up 1.7 years, range 5 months to 5 years).
Postoperative arrhythmias occurred in five patients, three of whom had
successful termination by antitachycardia pacemaker and two who had
pharmacologic control of their respective junctional ectopic and slow atrial
tachycardia. All patients have improved to New York Heart Association
class I or II. Conclusions: Total cavopulmonary artery conversion in
association with arrhythmia circuit cryoablation and atrial antitachycardia
pacemaker placement can be accomplished with low morbidity and mor-
tality, oftentimes resulting in dramatic increases in functional class and
control of life-threatening arrhythmias. (J Thorac Cardiovasc Surg 1998;
115:547-56)
The Fontan operation has undergone a number ofmajor modifications1-5 leading to the present-day
practice of total cavopulmonary artery connections
using lateral tunnel3 or extracardiac6 techniques.
Interatrial fenestration is often, but not always, used
depending on the number of patient risk factors7, 8
and institutional experience.9
However, a large number of Fontan patients had
variations of atriopulmonary artery connections be-
fore the present era. These, mostly older patients,
are at risk for anatomic obstructions and atrial
arrhythmias that usually lead to unfavorable hemo-
dynamics and systemic complications.10, 11 Recent
reports have shown improved functional class in
some patients after atriopulmonary artery Fontan
conversion to total cavopulmonary artery connec-
tion.12-15 Concomitant antiarrhythmia therapy con-
sisting of arrhythmia circuit cryoablation in these
patients has not been previously reported.
The purpose of this article is to review our
surgical experience with patients with atriopulmo-
nary artery Fontan operations who had obstructive
anatomic or arrhythmia indications for conversion
to total cavopulmonary artery connection, arrhyth-
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mia circuit cryoablation, and placement of atrial
antitachycardia pacemaker. Not included in this
review are the detailed perioperative electrophysi-
ologic (EP) analyses and relevant discussion that are
reported separately.16, 17
Materials and methods
Patient population. Between April 1992 and April
1997, 14 patients had conversion from atriopulmonary
artery to total cavopulmonary artery Fontan procedures
(lateral tunnel in eight, extracardiac in six). There were
seven male and seven female patients. The average age at
reoperation was 14 6 4 years, and the average time
interval between the last Fontan operation and the even-
tual conversion was 8 6 3 years. Two of these patients had
second-time conversions; one had two previously failed
atriopulmonary artery connections, and the other had an
initial atriopulmonary Fontan operation with acute failure
and takedown with a subsequent successful total cavopul-
monary artery fenestrated Fontan operation before our
current antiarrhythmia protocol was established.
Table I reviews clinical characteristics of our 14 pa-
tients, including primary diagnoses, previous Fontan con-
nections, indications for reoperation, components of the
Fontan conversion, and outcome. Indications for reopera-
tion were multiple and included New York Heart Associ-
ation (NYHA) functional class, debilitating atrial arrhyth-
mias, anatomic obstructions, interatrial shunts, and
valvular dysfunction. Nine patients were in NYHA class
IV, and three of these were considered for heart trans-
plantation because of severe functional limitation. Four
were in NYHA class III and the remaining patient was in
NYHA class II, but had life-threatening atrial tachycardia,
resulting in multiple syncopal episodes. Apart from func-
tional class, the primary indications for surgery were
debilitating atrial arrhythmias in 11, severe obstructive
lesions in 2, and bradycardia with cyanosis caused by a
right-to-left shunt in 1.
Operative procedure. The precise operative conversion
from atriopulmonary artery to cavopulmonary artery Fon-
tan largely depended on the preexisting venopulmonary
artery connections and the extent to which further pulmo-
nary artery reconstruction was necessary. Basically, three
types of anatomic connections were present: (1) seven
patients had atrial compartmentalization with right atrial–
pulmonary artery anastomosis (five anteroaortic and two
retroaortic connections), (2) six patients had a classic right
Glenn operation and an atrial–left pulmonary artery
anastomosis, and (3) one patient had an excellent ana-
tomic and hemodynamic result from a total cavopulmo-
nary artery, lateral tunnel, Fontan operation that was
performed after a remote unsuccessful atriopulmonary
connection. The indication for reoperation, reconversion,
and cryoablation in the last patient was recurrent, refrac-
tory atrial tachycardia with syncope originating in the
“left” atrial compartment.
The conduct of the operation was essentially the same
for all patients except for patients 1, 2, and 11, who did not
have concomitant arrhythmia circuit cryoablation.
Careful median sternotomy and relevant dissection
were followed by normothermic aortobicaval cardiopul-
monary bypass, allowing the heart to beat. In those
patients without a right-to-left residual shunt, a right
atriotomy was performed for intracardiac EP mapping
and cryoablation. A right atrial bipolar wire served as the
reference electrode and electrical pathway for arrhythmia
stimulation. EP mapping was accomplished by activation
sequence mapping during atrial reentry tachycardia (Fig.
1). An endocardial grid was used to sequentially map at
least four corridors of atrial tissue, moving superiorly to
inferiorly, at four to five sites for each corridor. These
results were compared with the preoperative mapping
findings. In some cases the areas of interest (e.g., the
coronary sinus and tricuspid valve) were in the pulmonary
atrium and could not be safely mapped without the risk of
air embolism. On the basis of EP arrhythmia circuit
identification, multiple cryoablation lesions were placed
(–60° C for 90 seconds each [Frigitronics, Shelton,
Conn.]) in a linear fashion between the coronary sinus os
and the inferior vena cava, between the tricuspid or
relevant atrioventricular valve anulus and the inferior
vena cava (Fig. 2, Area 1), along the full length of the
crista terminalis (Fig. 2, Area 2), along the length of the
superior septal limbus, and the os of the atrial appendage
(Fig. 2, Area 3). In general, Area 1 required 8 to 10
cryoablation lesions, Area 2 required 4 to 6 lesions, and
Area 3 required 3 to 5 lesions. Most of the cryoablation
lesions were placed during warm cardiopulmonary bypass
in a beating heart. When access to the compartmentalized
pulmonary atrium was required, further cryoablation was
delayed until systemic cooling and cardioplegic arrest
were established to avoid air embolism.
For the next phase of the operation (cavopulmonary
artery reconstruction), the patient is cooled to 32° C with
the heart allowed to beat. For those patients with atriop-
ulmonary anastomosis, a standard total cavopulmonary
artery reconstruction was accomplished with takedown of
the atriopulmonary artery connection. Extensive pulmo-
nary artery reconstruction, when necessary, was per-
formed at this time with polytetrafluoroethylene (PTFE)*
or homograft tissue. In those patients with a right Glenn
procedure and a right atrial–left pulmonary artery anas-
tomosis, more creative pulmonary artery reconstructions
were required (Figs. 3 and 4) with homografts and PTFE
tube grafts. At this point, the decision whether to use the
intraatrial lateral tunnel technique or the extracardiac
connection is made.
The third part of the operation was performed during
moderate systemic hypothermia (28° C) and cold blood
cardioplegic arrest. The previously constructed prosthetic
atrial septum was resected. During this time, left-sided
procedures are performed, including valvular reconstruc-
tions, completion of cryoablative lesions, the lateral tun-
nel reconstruction (when elected), transmural atrial wire
placement (Fig. 4) for the antitachycardia pacemaker
(Intertach II, Intermedics, Inc., Angleton, Tex.),17 ventric-
ular vent placement, atrial wall reduction (performed in
*Gore-Tex graft, registered trademark of W. L. Gore & Associ-
ates, Inc., Elkton, Md.
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Table I. Conversion to cavopulmonary Fontan procedure patients
Pt.
No.
Diagnosis/type of
initial Fontan
Age at
initial
Fontan
Interval
to redo
Age
at
redo Indications*
Concomitant
procedure Outcome
1 L-TGA, VSD, TS, AI; s/p
atriopulmonary an-
teroaortic Fontan
2 4 6 c Moderate AP obstruc-
tion with ascites
c Moderate aortic insuffi-
ciency
c Obstruction of right
pulmonary veins
c NYHA class III
c Conversion to TCPC
lateral tunnel fenes-
trated (3.5 mm) Fon-
tan
c Aortic valvuloplasty
c Reoperation for clam-
shell device deploy-
ment failure
NYHA class II; persis-
tent aortic insuffi-
ciency
2 Tricuspid atresia, bilateral
SVC; s/p atriopulmo-
nary anteroaortic Fon-
tan (valved conduit);
s/p conversion to atrio-
pulmonary retroaortic
Fontan
4
14
10
1
15 c Severe AP obstruction
with ascites
c NYHA class IV
c Conversion to TCPC
lateral tunnel fenes-
trated (6 mm) Fontan
Died of presumed
cerebral air embo-
lism
3 Tricuspid atresia; s/p atrio-
pulmonary anteroaortic
Fontan
3 8 11 c Severe SVT
c Moderate AP obstruc-
tion
c NYHA class III
c Conversion to TCPC
lateral tunnel fenes-
trated (5 mm) Fon-
tan
c Bilateral PA arterio-
plasty
c Cryoablation of ar-
rhythmia circuit
c Antitachycardia atrial
pacemaker
NYHA class I; digox-
in; 6 Episodes of
SVT terminated by
PM within first 3
mos only, none
thereafter
4 Double-inlet left ventricle,
subaortic stenosis, right
AV valve insufficiency;
s/p atriopulmonary ret-
roaortic Fontan and
subaortic resection
5 6 11 c Severe SVT
c NYHA class IV
c Conversion to TCPC
lateral tunnel Fontan
c Reduction right
atrioplasty
c Cryoablation of ar-
rhythmia circuit
c Antitachycardia atrial
pacemaker
NYHA class I; ateno-
lol; 2 Episodes of
SVT terminated by
PM within first 3
mos only; slow
atrial tachycardia
21 mos postop
controlled by
atenolol
5 Tricuspid atresia; s/p atrio-
pulmonary anteroaortic
Fontan
5.5 7.5 13 c Severe SVT
c Moderate AP obstruc-
tion
c NYHA class III
c Conversion to TCPC
lateral tunnel Fontan
c Cryoablation of ar-
rhythmia circuit
c Antitachycardia atrial
pacemaker
NYHA class I; no
medications; no
SVT
6 Tricuspid atresia; s/p atrio-
pulmonary anteroaortic
Fontan
6 11 17 c Profound bradycardia
and nonsustained SVT
c Severe AP obstruction
c NYHA class IV
c Conversion to TCPC
lateral tunnel Fontan
c Cryoablation of ar-
rhythmia circuit
c Antitachycardia atrial
pacemaker
NYHA class II; no
medications; no
SVT
7 L-transposition with single
ventricle, mitral steno-
sis, restricted bulboven-
tricular foramen; s/p
Damus-Stansel-Kaye;
s/p right Glenn and left
atriopulmonary ret-
roaortic Fontan
6 6 12 c Severe SVT
c R3L shunt
c NYHA class IV
c Conversion to TCPC
extracardiac (20 mm
PTFE graft) Fontan
c Ligation hepato-LA
communicating vein
c Cryoablation of ar-
rhythmia circuit
c Antitachycardia atrial
pacemaker
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Table I. Cont’d
Pt.
No.
Diagnosis/type of
initial Fontan
Age at
initial
Fontan
Interval
to redo
Age
at
redo Indications*
Concomitant
procedure Outcome
8 Tricuspid atresia; s/p atrio-
pulmonary retroaortic
Fontan
5.5 9.5 15 c Severe SVT
c Moderate AP obstruction
c NYHA class IV
c Conversion to TCPC extra-
cardiac (24 mm PTFE
graft) Fontan
c PA arterioplasty
c Cryoablation of arrhythmia
circuit
c Antitachycardia atrial pace-
maker
NYHA class I; digoxin;
no SVT
9 L-TGA, double-inlet left
ventricle, pulmonary
atresia; s/p right Glenn
and left atriopulmonary
retroaortic Fontan
9 10 19 c Severe SVT
c Severe RPA stenosis
c Mild LPA stenosis
c NYHA class IV
c Conversion to TCPC lat-
eral tunnel Fontan
c LPA Palmaz stent
c Cryoablation of arrhythmia
circuit
c Antitachycardia atrial pace-
maker
NYHA class II; digoxin
1 procainamide;
adenosine-sensitive
SVT not terminated
by PM 1 mo postop
controlled by pro-
cainamide
10 L-TGA, single ventricle
with bulboventricular
foramen, mitral atresia;
s/p right Glenn and left
atriopulmonary retroaor-
tic Fontan
11 10 21 c Severe SVT
c Pulmonary venous ob-
struction
c NYHA class III
c Conversion to TCPC lat-
eral tunnel Fontan
c Cryoablation of arrhythmia
circuit
c Antitachycardia atrial pace-
maker
NYHA class I; digoxin;
slow atrial tachycar-
dia; SVT terminated
by PM within first 3
mos, none thereafter
11 TGA with single RV and
PS; s/p right Glenn and
left atriopulmonary ret-
roaortic Fontan
8 8 16 c Bradycardia
c Mild RPA-venous fistula
with R3L shunt
c NYHA class IV
c Conversion to TCPC extra-
cardiac (22 mm aortic ho-
mograft) Fontan
c AAI pacemaker
NYHA class I; no SVT
12 DORV with mitral atresia;
s/p right Glenn and left
atriopulmonary retroaor-
tic Fontan w/tricuspid
valvuloplasty
5 8 13 c Bradycardia, SVT
c RV dysfunction
c NYHA class IV
c Conversion to TCPC extra-
cardiac (24 mm aortic ho-
mograft) Fontan
c Cryoablation of arrhythmia
circuit
c Antitachycardia atrial pace-
maker
NYHA class I; digoxin;
no SVT
13 L-TGA, single ventricle,
mitral atresia, severe PS;
s/p right Glenn and left
atriopulmonary retroaor-
tic Fontan
4.5 7.5 12 c Severe SVT
c Persistent LSVC to the
LA with R3L shunt
c Mild LPA stenosis
c NYHA class IV
c Conversion to TCPC extra-
cardiac (composite 20 mm
aortic homograft and 20
mm PTFE graft) Fontan
c Ligation LSVC
c Left PA arterioplasty
c Cryoablation of arrhythmia
circuit
c Antitachycardia atrial pace-
maker
NYHA class I; digoxin;
no SVT
14 L-TGA, single ventricle
with restrictive bulbo-
ventricular foramen; s/p
AP window and atrio-
pulmonary retroaortic
Fontan with emergency
takedown to S-P shunt;
s/p TCPC lateral tunnel
fenestrated (5 mm)
Fontan
7.5
8
0.5
7
15 c Severe SVT
c NYHA class II
c Conversion to TCPC extra-
cardiac (22 mm TPFE
graft) Fontan
c Cryoablation of arrhythmia
circuit
c DDD pacemaker
NYHA class I; digoxin;
early heart block;
JET, resolved; no
SVT
AI, Aortic insufficiency; AP, atriopulmonary; AP window, aortopulmonary window; AV, atrioventricular; DORV, double-outlet right ventricle; LA, left atrium;
LPA, left pulmonary artery; LSVC, left superior vena cava; L-TGA, L-transposition of the great arteries; NYHA, New York Heart Association; PA, pulmonary
artery; PM, pacemaker; PS, pulmonary stenosis; RA, right atrium; RPA, right pulmonary artery; RV, right ventricle; R3L, right-to-left; s/p, status post; S-P,
systemic–to–pulmonary artery; SVC, superior vena cava; SVT, supraventricular tachycardia; TCPC, total cavopulmonary artery connection; TS, tricuspid
stenosis; VSD, ventricular septal defect.
*AP obstruction was rated by atriopulmonary artery pressure gradient (mm Hg): mild .1 to 2 mm Hg; moderate 2 to 3 mm Hg; severe .3 mm Hg. Severe
SVT was defined as SVT causing hemodynamic compromise or syncopal episodes, repeated hospitalizations, and requiring multiple antiarrhythmic
medications.
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most patients), and atriorrhaphy. The atrial pacemaker
lead is placed in the “red” atrium by means of the
transmural technique reported by Hoyer and associates.18
This is followed by de-airing, aortic crossclamp removal,
rewarming, vent removal, and extracardiac inferior vena
cava connection when elected (Figs. 3, 4). Separation
from cardiopulmonary bypass is followed by transesoph-
ageal echocardiographic assessment. Patients were usually
extubated the following day and underwent EP study and
attempted arrhythmia induction before hospital dis-
charge.
Follow-up. Clinical status was assessed on the basis of
the functional classification of the NYHA. Arrhythmia
assessment included review of clinical history, electrocar-
diograms, 24-hour continuous Holter monitoring, and
pacemaker interrogation at regular 3-month intervals. All
patients were placed on lifelong warfarin sodium (Cou-
madin) therapy (international normalized ratio main-
tained in the 1.5 to 2.0 range). Specific antiplatelet therapy
was not used.
Results
One perioperative death occurred (7%) in a
patient undergoing second-time Fontan revision.
Conversion to total cavopulmonary artery, lateral
tunnel, fenestrated Fontan resulted in a favorable
hemodynamic result. However, the patient died 4
days later of presumed cerebral air embolism and
the low-flow state that accompanied unwanted cav-
itary entry during the resternotomy.
Resternotomy was accomplished safely and with-
out significant cavitary entry in 12 of 14 patients.
Two patients had unwanted cavitary entry during
the resternotomy. One of these (second-time redo
Fontan, discussed above) was managed by expedi-
tious femoral-femoral partial cardiopulmonary by-
pass with intracavitary cardiotomy sucker assistance
until completion sternotomy and aortobicaval car-
diopulmonary bypass could be established. Another
patient was quickly managed with femoral-femoral
partial cardiopulmonary bypass but without intra-
cavitary cardiotomy sucker assistance. This pre-
vented air from entering the right atrium and al-
lowed completion sternotomy with aortobicaval
conversion without a period of instability. The pa-
tient had no complications after a successful Fontan
conversion and arrhythmia circuit cryoablation. Sub-
sequently, one patient with a gigantic right anterior
atrium was placed on femoro-femoral bypass for
atrial decompression before sternotomy. This was
then converted to aortobicaval cannulation for the
conduct of the operation.
One patient required reoperation (during the
same admission) for retrieval of a Lock clamshell
device (USCI/C.R. Bard, Inc., Bellerica, Mass.) af-
ter a failed attempt at postoperative atrial fenestra-
tion closure. We have since abandoned atrial fenes-
Fig. 1. Diagrammatic representation of an open right
atrial view in an atriopulmonary Fontan patient, without
residual atrial shunts, who has been placed on normother-
mic aortobicaval cardiopulmonary bypass en route to EP
mapping and arrhythmia circuit cryoablation, cavopulmo-
nary artery conversion, and atrial antitachycardia pace-
maker placement. A right atrial bipolar wire served as the
reference electrode and electrical pathway for arrhythmia
stimulation. A hand-held electrode is used to perform the
EP mapping.16
Fig. 2. Diagrammatic representation of an open right
atrial view (see Fig. 1). Tachycardia was localized in three
major areas: Area 1, the area between the coronary sinus
os and the inferior vena cava os, as well as the area
between the atrioventricular valve anulus and the inferior
vena cava os; Area 2, the lateral atriotomy, which corre-
sponded to the length of the crista terminalis; and Area 3,
the region at the superior limbus corresponding to the
prior atrial septal defect patch.
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tration for these patients, speculating that
postoperative improved hemodynamics and mainte-
nance of systemic oxygen saturation will benefit the
patient more than the enhanced cardiac output and
obligatory systemic desaturation that accompanies a
fenestration.19
Transmural steroid-eluting atrial leads and atrial
antitachycardia pacemakers were placed in 10 pa-
tients who had arrhythmia circuit cryoablation. The
rationale for this therapy is that the atrial wire is
more easily placed at the revision operation than at
a future time of need when obligatory thoracotomy
would be necessary, and that the atrial antitachycar-
dia pacemaker may be needed in the event of
recurrent atrial tachycardia or the development of a
new atrial arrhythmia that might arise from existing
atrial suture lines. One patient with sinus bradycar-
dia had an atrial rate-responsive (AAIR) pacemaker
and another patient with single ventricle and L-
transposition had a dual-chamber (DDD) pace-
maker placed because of atrioventricular dissocia-
tion after arrhythmia circuit cryoablation.
Postoperatively, the patient regained normal atrio-
ventricular node function without inducible atrial
tachycardia, which allowed pacemaker conversion to
an AAI mode. Should atrial tachycardia recur, this
pacemaker may be manually programmed for ar-
rhythmia conversion. The remaining two patients
had total cavopulmonary artery conversion before
our arrhythmia protocol was initiated.
The average postoperative length of stay in the
remaining 13 survivors was 10 6 3 days. Chest tube
output was minimal (removal of last chest tube,
postoperative day 7 6 3). Postoperative atrial tachy-
cardia developed in one patient (No. 9) while re-
ceiving inotropic support, requiring procainamide
infusion. Another patient (No. 14) had transient
junctional ectopic tachycardia develop responding
to intravenous amiodarone, which was subsequently
withdrawn with no evidence of inducible supraven-
tricular tachycardia before discharge.
No long-term deaths occurred. The mean dura-
tion of follow-up in the 13 survivors is 1.7 years
(standard deviation 1.6 years, range 5 months to 5
years). All patients are currently considered to be in
NYHA class I or II, with resumption of normal
activities. Among the 11 patients whose primary
indication for reoperation was medically refractory
atrial tachycardia, only 2 patients are receiving
antiarrhythmic medications other than digoxin. One
patient (No. 9, see above) had a single clinical
recurrence of adenosine-sensitive atrial tachycardia
4 weeks postoperatively, and no recurrences in the
subsequent 14 months while taking procainamide;
Fig. 3. Diagrammatic representation of a total cavopulmonary artery extracardiac conversion in a patient
with an established classic right Glenn/right atrium–to–left pulmonary artery Fontan connection. An aortic
homograft was used to connect the left pulmonary artery with the inferior vena cava using the favorable
curve of the ascending and transverse arch of the homograft. The Glenn anastomosis was connected
side-to-side to the homograft to complete the reconstruction. A transmural bipolar steroid-eluting atrial
lead (Medtronic, Inc., Minneapolis, Minn.) is placed in the left atrial appendage for antitachycardia
pacemaker placement. Ao, Aorta; APL, antitachycardia pacemaker lead; IVC, inferior vena cava; SVC,
superior vena cava; LPA, left pulmonary artery; RPA, right pulmonary artery.
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her preoperative arrhythmia was not adenosine-
sensitive. Another patient (No. 4) with incessant,
hemodynamically unstable rapid atrial tachycardia
preoperatively, had a slow, asymptomatic atrial
tachycardia develop 21 months postoperatively, re-
sponding to b-blocker therapy. In the 10 patients
with atrial antitachycardia pacemakers, tachycardia
has been successfully detected and terminated by
the pacemaker in three of 10 patients (Table I), all
occurring in the first 3 months postoperatively, with
no subsequent recurrences. None of these patients
have been aware of clinical episodes of tachycardia.
Discussion
Improved modifications of the Fontan operation
have resulted in today’s accepted practice of total
cavopulmonary artery (lateral tunnel or extracar-
diac) connections.3-11, 19 Long-term follow-up will
determine the efficacy of these techniques with
regard to improved hemodynamics and arrhythmia
control.3, 4, 6, 8, 19-23 However, increasing concern ex-
ists that atriopulmonary Fontan patients, who un-
derwent repair before the present era, are at risk for
anastomotic obstructions and atrial arrhythmias.12-
15, 24-29 In addition, pulmonary arteriovenous fistulas
are frequently present in those patients with discon-
tinuous pulmonary arteries caused by an established
right Glenn procedure and atrial–left pulmonary
artery connections.30 Other patients will have left-
sided valvular or obstructive lesions, acquired right-
to-left shunts, and protein-losing enteropathy devel-
op.10, 11, 31
Reoperation in patients with atriopulmonary
Fontan procedures to correct obstructive lesions
and convert them to total cavopulmonary artery
connections has been successfully performed by
several groups.12-15 Hemodynamic improvement
and increase in functional class were achieved in
most patients with acceptable mortality and morbid-
ity. Our experience compares favorably with these
reports, demonstrating a low mortality (7%) and a
uniform increase in functional class. The signifi-
cance of these cumulative results is profound con-
sidering that the only alternative for many of these
patients is cardiac transplantation, which was subse-
quently performed once in McElhinney’s series13
and once in Kreutzer’s series.14
The rationale for arrhythmia therapy in these
previously reported cases12-15 was based on reduc-
tion atrioplasty and elimination of the high-pressure
atrium25-27 by lateral tunnel or extracardiac tech-
niques. Except for perioperative atrial antitachycar-
dia pacemaker placement in selected patients, no
specific attempt at arrhythmia circuit interruption
was made. As a consequence, atrial arrhythmias
persisted in a significant number of their patients
and developed anew in others who had extensive
atrial reduction.13 These results are not surprising
based on experimental animal studies by Gandhi
and associates32 that implicated preexisting Fontan
Fig. 4. Total cavopulmonary artery extracardiac Fontan conversion (see Fig. 3). Occasionally, the aortic
homograft may require a PTFE graft extension (composite graft) to connect the left pulmonary artery with
the inferior vena cava. The Glenn anastomosis can be connected to the homograft as appropriate.
Abbreviations as in Fig. 3.
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intraatrial suture lines as the substrate for reentry
atrial tachycardia. In a concurrent comparative clin-
ical report,16 we found that atriopulmonary Fontan
conversion to total cavopulmonary artery connec-
tion without arrhythmia circuit cryoablation results
in uniform recurrence of atrial arrhythmias, sup-
porting in human beings what was found in Gandhi’s
animal studies.32 We conclude from these studies
that preexisting Fontan atrial suture lines are critical
to the pathogenesis of reentry atrial tachycardia and
that relief of atrial hypertension by means of lateral
tunnel or extracardiac techniques, although impor-
tant for optimal hemodynamic results, will not ef-
fectively control atrial arrhythmias unless accompa-
nied by arrhythmia circuit cryoablation.
Reoperation in Fontan patients with established
atriopulmonary artery connection (with or without
discontinuous pulmonary arteries) involves three
important components to achieve improved hemo-
dynamics and effective arrhythmia control. The first
is safe resternotomy and effective total cavopulmo-
nary artery reconstruction; the second is EP map-
ping and comprehensive arrhythmia circuit cryoab-
lation; and the third, in our practice, is the
prophylactic placement of an atrial antitachycardia
pacemaker.
Resternotomy in Fontan patients with large, thin-
walled, and oftentimes anterior right atria requires
careful consideration of anatomic and pathophysio-
logic conditions that can easily be destabilized in the
event of unwanted and uncontrolled cavitary entry.
Indeed, one of our patients eventually died because
of a presumed cerebral air embolism caused by
cavitary entry during resternotomy despite expedi-
tious femoral cannulation and effective total cavo-
pulmonary artery conversion. In selected patients
with the aforementioned risk factors (one in this
series), we recommend femoral artery–femoral vein
partial cardiopulmonary bypass to decompress the
right atrium for more effective and safer resterno-
tomy.13 After dissection, conversion to aortobicaval
cannulation and femoral vessel repair is performed.
Conversion from atriopulmonary to total cavopul-
monary artery connection is relatively straightfor-
ward. In most cases, the pulmonary arteries must be
completely dissected because a significant number
of connections are anteroaortic and should be con-
verted to a retroaortic position. All pulmonary
artery stenoses should be addressed by arterioplasty
(we prefer PTFE), which can be followed by intra-
atrial lateral tunnel or extracardiac inferior vena
cava–pulmonary artery connection. The retrospec-
tive reconstructive trends in this small series of
patients are less use of atrial fenestration and
greater use of aortic homografts and PTFE tubes for
the extracardiac connection.6, 20, 21 Our unsubstanti-
ated bias is to avoid atrial fenestration and systemic
desaturation despite the increased cardiac output19
in favor of the resultant improved hemodynamics in
a patient already adapted to the increased systemic
venous pressure of the “Fontan physiology.” The
extracardiac connection is attractive because it is
generally easier to perform and has the added
benefit of fewer atrial suture lines that are one of the
substrates for atrial tachycardia.33
The exact sites for arrhythmia circuit cryoablation
in our patients were based on perioperative EP
studies16 and previous reports34-36 that defined the
predominant anatomic critical isthmus for slow con-
duction in the area between the coronary sinus os,
tricuspid anulus, and the inferior vena cava os. We
identified three major anatomic sites thought to be
critical to the tachycardia circuit (Fig. 2). These
were Area 1, the area between the coronary sinus os
and the inferior vena cava os, as well as the area
between the atrioventricular valve anulus and the
inferior vena cava os; Area 2, the lateral atriotomy,
which corresponded to the length of the crista
terminalis; and Area 3, the region at the superior
limbus corresponding to the rim of the prior atrial
septal defect patch. All patients had cryoablation
lesions placed in Area 1. In those selected patients
requiring further therapy in Areas 2 and 3, cryoab-
lation lesions were linearly placed to connect these
areas with an anatomic orifice (i.e., vertical lesions
along the crista terminalis from the superior vena
cava to the inferior vena cava or lesions to connect
the superior limbus to the superior vena cava). With
this strategy, all patients had acutely successful atrial
arrhythmia ablation, although two patients had new
atrial arrhythmias develop that were easily con-
trolled with single-drug therapy.
Although we believe that the cryoablation tech-
nique is critical to interrupt the reentrant tachycar-
dia circuit, the limitations of our mapping technique
and the possibility of creating new arrhythmia sub-
strates may result in postoperative tachycardia.
Transvenous catheter access to the heart for radio-
frequency catheter ablation or pacing will be limited
postoperatively, particularly in patients with an ex-
tracardiac tunnel. Reoperation for placement of an
antitachycardia pacemaker will require an addi-
tional sternotomy. The rationale for the atrial wire
and antitachycardia pacemaker represents “backup
The Journal of Thoracic and
Cardiovascular Surgery
March 1998
5 5 4 Mavroudis et al.
therapy” in the event of cryoablation failure.
Early in our experience, finding a favorable right
atrial wire location for the antitachycardia pace-
maker was often problematic because of the en-
docardial fibrosis often present in the right side of
the atrium. We subsequently found that the left
atrial appendage is a superior site, yielding favor-
able EP measurements.17 The advantages of this
technique include accurate wire placement and
fixation aided by cardioplegic arrest and lack of
left atrial endocardial fibrosis because reconstruc-
tive suture lines are rarely placed in this area. The
disadvantage of this technique is that the atrial
wire can only be tested after cavitary closure and
separation from cardiopulmonary bypass, when
manipulation is severely limited. Thus far, we
have not experienced systemic complications from
the left-sided atrial wires, perhaps owing to the
improved hemodynamics and long-term warfarin
administration.37 We therefore continue to rec-
ommend prophylactic atrial antitachycardia pace-
maker placement in these patients to add another
measure of therapy should cryoablation fail or a
new arrhythmia circuit develop.
The primary indication for surgery in most of our
patients was medically refractory atrial arrhythmias
associated with syncope, stroke, or severe functional
incapacity. Present-day management of atrial tachy-
cardia in Fontan patients by pharmacotherapy,38
radiofrequency ablation,34-36 and antitachycardia
pacing39 has met with variable success and signifi-
cant morbidity.38 Our own comparative study16 and
reports from others12-15, 28 indicate that Fontan con-
version without specific arrhythmia therapy im-
proves hemodynamics but does not alter the course
of atrial arrhythmias. We have shown that intraop-
erative mapping and selective cryoablation can in-
terrupt the arrhythmia circuit in most patients with-
out pharmacotherapy or dependence on atrial
antitachycardia pacemakers.
Reoperation in Fontan patients with significant
debilitating atrial arrhythmias with or without ob-
structive lesions can be accomplished with low mor-
bidity and mortality, resulting in oftentimes dra-
matic increases in patient activity and function. We
recommend that patients with atriopulmonary ar-
tery Fontan connections be closely followed up for
obstructive lesions, valvular dysfunction, and atrial
arrhythmias with a low threshold for reoperation,
even if the only indication is debilitating atrial
arrhythmias. Prophylactic cryoablation in first-time
Fontan reconstructions to prevent atrial arrhythmias
is an intriguing issue that will require a controlled
study to determine its efficacy.
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